🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UnitedHealth shares get a boost with raised target, Buy rating

EditorAhmed Abdulazez Abdulkadir
Published 17/07/2024, 16:48
UNH
-

On Wednesday, UnitedHealth Group Inc. (NYSE: NYSE:UNH) saw its price target increased to $600 from the previous $570, while retaining a Buy rating, as announced by a market analyst firm. The firm's decision follows UnitedHealth Group's resilience in the face of a cyberattack that caused a temporary halt to the Change Healthcare (NASDAQ:CHNG) claims processing and payments network.

The company's UnitedHealthcare and Optum segments have reportedly shown robust revenue growth despite the cyber incident. The analyst noted that medical utilization trends are aligning with expectations, suggesting a stable operational environment for the healthcare giant.

Significant revenue increases were highlighted in the Optum Health and Optum Rx divisions, both recording a 13% rise. Furthermore, the analyst pointed out that Optum Insight's growing backlog is anticipated to contribute to revenue and earnings expansion within the health services segment for the year 2024.

In other recent news, UnitedHealth Group has seen several updates to its stock price target by various financial firms. Wells Fargo (NYSE:WFC) increased the price target to $630, citing potential positive developments in 2025. Meanwhile, Baird raised its price target to $640, expressing confidence in the healthcare giant's performance.

RBC Capital also raised its target to $615, noting a solid performance in the Medicare business. Jefferies significantly increased the price target from $481 to $647, based on expectations of strong Medicare Advantage growth with better margins by 2025. Truist Securities also raised the price target to $640, following UnitedHealth's robust second-quarter performance and reaffirmed full-year 2024 guidance.

These updates reflect recent developments and analysts' confidence in UnitedHealth Group's ability to navigate market conditions and maintain its growth trajectory. However, UnitedHealth Group has also faced challenges, including a Federal Trade Commission scrutiny over its pharmacy-benefit management pricing strategies and a cyberattack compromising the private data of an estimated one-third of Americans.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.